Related Experiment Video
Updated: Jul 25, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Managing the Drug-Drug Interaction With Apixaban and Primidone: A Case Report.
Melanie M Manis1, Kat Petersen1, Megan Z Roberts1
1Samford University McWhorter School of Pharmacy, Birmingham, AL, USA.
Managing drug interactions between primidone and apixaban is complex. This case report details a strategy for a patient with venous thromboembolism, highlighting the need for more research on this specific drug combination.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Drug Interactions
Background:
- Primidone is a moderate to strong cytochrome P-450 (CYP) 3A4 inducer.
- Apixaban is a direct oral anticoagulant (DOAC) and a CYP3A4 substrate.
- Managing the drug-drug interaction (DDI) between primidone and apixaban is challenging due to limited evidence.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

